BioMérieux BioMérieux H1 Revenues Rise 7 Percent Growth in immunoassay business segment sales was offset by a decline in molecular biology sales, the firm said. Startup BioFlyte Detects Airborne SARS-CoV-2 Using BioFire FilmArray Premium BioFlyte has developed a system to collect pathogens from ambient air, detecting and identifying them using the FilmArray system from BioFire. BioMérieux Receives CE Mark for Vitek Clinical Microbiology Mass Spec System The company said it plans to launch the instrument in selected European and Asian markets in the second half of 2021, with a global launch planned for 2022. BioMérieux Reports 10 Percent Q1 Revenue Growth, Lowers Full-Year Guidance The firm now guides for neutral to mid-single digit growth in 2021, decreased from a prior range of 5 percent to 8 percent growth. BioFire Dx Receives First FDA Marketing Clearance for SARS-CoV-2 Respiratory Panel The test is the first COVID-19 assay to transition from Emergency Use Authorization to a cleared regulatory status. Feb 24, 2021 BioMérieux Reports 21 Percent Revenue Growth in Q4 Dec 23, 2020 In Brief This Week: Natera, Sync for Genes, Castle Biosciences, BioMérieux, PathogenDx, More Dec 16, 2020 BioMérieux Nabs CE Mark for RT-PCR SARS-CoV-2, Influenza A/B Assay Dec 8, 2020 BioMérieux Coronavirus Test Gets FDA OK for Use With Pooled Samples Oct 22, 2020 BioMérieux Q3 Revenues Increase 21 Percent Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 2, 2020 BioMérieux Posts 16 Percent Sales Growth for First Half of 2020 Jul 21, 2020 AdvaMed Partners With Dx Companies to Create National COVID-19 Supply Registry Jul 15, 2020 BioMérieux BioFire Respiratory Panel With SARS-CoV-2 Target Nabs CE Mark Jul 9, 2020 BioMérieux Reports 62 Percent BioFire FilmArray Sales Growth in Preliminary Q2 Release May 19, 2020 BioMérieux's BioFire Pneumonia Panel Could Improve Care, Find Secondary Infection in COVID-19 Cases Premium May 8, 2020 BioMérieux Gets US Emergency Use Authorization for SARS-CoV-2 R-Gene MDx May 4, 2020 BioMérieux's BioFire SARS-CoV-2 Respiratory Panel Wins FDA Emergency Use Authorization Apr 16, 2020 BioMérieux Reports 22 Percent Q1 Revenue Growth, Withdraws Full-Year Guidance Mar 24, 2020 BioMérieux Rapid Coronavirus Test Gets FDA Emergency Use Authorization Mar 20, 2020 Commercial Coronavirus Test Developers Tweak Timelines, EUA Plans in Light of Loosened FDA Guidance Mar 12, 2020 Jury Rules in Favor of Hologic, Grifols in BioMérieux Patent Infringement Lawsuit Mar 12, 2020 DIAMONDS Project Using New Classification Approach to Develop Rapid Infectious Disease Tests Premium Feb 26, 2020 BioMérieux Reports 11 Percent Revenue Growth in Q4 Jan 14, 2020 BioMérieux Submits 43-Target BCID2 Test to FDA Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.